Last reviewed · How we verify
NCT03779282
KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery
trial testing Dexmedetomidine in Emergence Delirium in 90 participants. Completed in 15 September 2018.
15 September 2018
Quick facts
| Lead sponsor | Ochsner Health System |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 90 |
| Start date | 15 February 2018 |
| Primary completion | 15 September 2018 |
| Estimated completion | 15 September 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Dexmedetomidine (dexmedetomidine) — full drug profile →
Conditions studied
- Emergence Delirium — all drugs for Emergence Delirium →
- Strabismus — all drugs for Strabismus →
Sponsor
Ochsner Health System — full company profile →
Who can join
Under 18, any sex, with Emergence Delirium or Strabismus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Strabismus surgery for children is a very common procedure, with a high incidence of emergence delerium in the recovery room. A combination of intravenous ketamine/dexmedetomidine, or ketodex, has been previously shown to reduce emergence delerium in children undergoing adenotonsillectomy. Here, we study its application in strabismus surgery.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Publication bias in pediatric emergence delirium: a cross-sectional analysis of ClinicalTrials.gov and ClinicalTrialsRegister.eu.
Meyburg J, Ries M. · · 2020 · cited 5× · PMID 33060081 · DOI 10.1136/bmjopen-2020-037346
Verify or expand the search:
- PubMed search for NCT03779282
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Dexmedetomidine
Trials testing the same drug.
- NCT06824077 — Reducing Days DELirious With DEXmedetomidine as Part of an Intensive Care Unit Sleep Promotion Bundle · EARLY_PHASE1 · not yet recruiting
- NCT07398066 — DEXmedetomidine for Postoperative Analgesia and Delirium Prevention After NEUROsurgery (DEX-NEURO Trial) · NA · not yet recruiting
- NCT07377981 — An Exploratory Study of the Efficacy and Safety of Esketamine and Dexmedetomidine in Non-Intubated ICU Patients With Hyp · Phase 4 · not yet recruiting
- NCT07306702 — Dexmedetomidine-Enhanced PCIA After Lobectomy in Nicotine-Dependent Patients · Phase 4 · withdrawn
- NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
Other recruiting trials for Emergence Delirium
Currently open trials in the same condition.
- NCT07435675 — Efficacy of Ultrasound-guided Greater Auricular Nerve Block in Preventing Postoperative Emergence Agitation in Pediatric · NA · recruiting
- NCT05541276 — MELAtonin for Prevention of Postoperative Agitation and Emergence Delirium in Children · Phase 3 · recruiting
- NCT07046364 — Remimazolam and Emergence Delirium in Pediatrics · Phase 4 · recruiting
- NCT06761092 — Nebulized Dexmedetomidine for Post-Anesthesia Delirium in Preschool Children · Phase 4 · active not recruiting
- NCT06545786 — Intraoperative Diagnosis of Neurocognitive Complications Via Electroencephalographic Analysis · recruiting
Other Ochsner Health System trials
Trials by the same sponsor.
- NCT07516327 — Cold and Compression After Rotator Cuff Repair (RCR) · NA · recruiting
- NCT07226973 — Gait After THA: Direct Anterior vs Manual Posterior vs Robotic Posterior · NA · recruiting
- NCT06920563 — Remote Postpartum Blood Pressure Monitoring and Cardiovascular Education · NA · recruiting
- NCT06613191 — Colonoscopy and Antiplatelet Therapy Trial · Phase 4 · not yet recruiting
- NCT05516641 — Prebiotics in Rectal Cancer · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03779282 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ochsner Health System
- Last refreshed: 19 December 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03779282.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing